Lorianne Masuoka, M.D.

Lorianne Masuoka, M.D.

Chief Medical OfficeratDiaMedica Therapeutics· In the 2024 proxy

Pay in FY2024DiaMedica Therapeutics stock +91.2% the same year

Lorianne Masuoka, M.D. was paid $1.2M in FY2024 (Dec). DiaMedica Therapeutics stock rose 91.2% that year.

Pay$100 in the stock at the end of FY23 → $191
Pay is from the Summary Compensation Table of each DiaMedica Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. DiaMedica TherapeuticsPublic company · 2 yr
    • Chief Medical Officer2024 – Present · 2 yrStock in role +247%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?